With reference to the 2022-23 financial year budget report of the South African Health Products Regulatory Authority, whose objective is to, amongst others, monitor and evaluate, regulate, investigate, inspect, register and control of medicines, clinical trials and devices relating to public health matters, only 22% of new Good Manufacturing Practices and Good Warehouse Practices related to licenses were finalised in 125 days, what (a) are the financial implications for those whose licenses were submitted and not granted, (b) were the reasons the licences were not granted and (c) licenses were not granted?